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Cisteine Residues Involved in Transport Activity and Nitric Oxide Sensi-
tivity of the Cationic Amino Acid Transporter CAT-2A
Ruifang Zheng, R. Daniel Peluffo.
UMDNJ-New Jersey Medical School, Newark, NJ, USA.
The cationic amino acid transporter CAT-2A is a low-affinity, high-capacity
carrier expressed in cardiomyocytes, liver and other tissues. CAT-2A is sensi-
tive to N-ethylmaleimide (NEM) and nitric oxide (NO) inhibition. Both reac-
tions involve cysteine (Cys) modification. Our previous studies showed that
mutating Cys347 to alanine (C347A) in mouse CAT2A (mCAT2A) results in
a ~60% decrease in transport activity, and insensitivity to NO inhibition with-
out affecting membrane expression levels of this transporter. The decreased
activity might be due to a disruption of the Cys local environment. Alterna-
tively, this Cys could be directly implicated in transport activity. We decided
to test these possibilities by replacing Cys347 with a ‘‘more conservative’’
serine (C347S). Serine has similar size/polarity as Cys, but lacks the -SH group.
The C347S mutant shows transport activity comparable to that of wild type;
however, it retains NO insensitivity. To learn more about the involvement of
Cys347 in transport, we measured the L-Lys concentration dependence of
uptake in the presence of radiotracer amounts of [14C]L-Lys in both wild-
type and C347A mCAT-2A variant. Hyperbolic fitting yielded not significantly
different Km values (6.35 2.8 vs. 8.25 0.4 mM) and a substantial decrease in
Vmax (2.6 5 0.6 vs. 4.7 5 0.1 nmol/mg prot./min) for C347A compared to
wild-type control. These data suggest an impaired transporter turnover rate
when Cys347 is replaced with Ala. In conclusion, Cys347 -SH side chain is
required for NO modulation of mCAT-2A and the size/polarity of residue
347 is critical for the normal functioning of this transporter.
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Topology of Human Proton-Coupled Folate Transporter Expressed in
E. Coli
Swapneeta Date, Phaneendra K. Duddempudi, Michaela Jansen.
Texas Tech University Health Sciences Center, Lubbock, TX, USA.
The proton-coupled folate transporter (PCFT) is an important membrane pro-
tein involved in the absorption of folates in humans. Folic acid is considered
a vitamin that plays important roles in crucial one carbon transfer reactions.
Folates are especially important for processes where DNA synthesis is
involved, as for example fetal development and cancer. Humans cannot synthe-
size folates and therefore, absorption from the diet is the only source. Point
mutations in PCFT manifest in form of Hereditary Folate Malabsorption Syn-
drome (HFM). PCFT is also involved in cancer treatment by providing the
uptake pathway for antifolate anticancer agents. So far very limited information
is available about PCFT’s structure and function. To obtain large quantities of
human PCFT for structural studies, we have generated a PCFT construct that
expresses well in membranes of E. coli. To ascertain correct folding of
PCFT after over-expression in E. coli, we carried out a detailed topological
study using the substituted Cysteine accessibility method (SCAM), comparing
the accessibility of engineered single-Cys in PCFT expressed in E. coli vs.
PCFT expressed in Xenopus laevis oocytes. Correctly folded PCFT produced
in E. coli will be a potent tool for further structural and mechanistic studies
of folate translocation by PCFT that will aid in the development and optimiza-
tion of therapies against HFM and cancer.
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Biophysical Properties of a Human Plasma-Membrane Creatine
Transporter
Jayalakshmi Ramachandran, Jorge E. Contreras, R. Daniel Peluffo.
UMDNJ-New Jersey Medical School, Newark, NJ, USA.
Creatine (Cr) and phosphocreatine play central roles in energy storage and
transport/shuttle of high-energy phosphate in cardiac and skeletal muscle. Cr
is taken up from the circulation by a Na,Cl-dependent cotransporter. The mech-
anism of this secondary-active transport process as well as the effect of the cell
membrane potential (VM) on Cr transport are poorly understood. To study the
biophysical features of this process, the human isoform of the plasma-
membrane creatine transporter (SLC6A8) was subcloned and expressed in
Xenopus oocytes. Cr-activated inward currents were measured by two-
electrode voltage clamp as a function of 2-200 mM [Cr]o in buffer containing
150 mM NaCl at 22C. The [Cr]o that half-maximally activated current
(K0.5) was largely VM-independent (range 180 to 0 mV) and had an average
value of 125 1 mM (S.E., n = 9). Maximal current levels (Imax), normalized to
the value at the holding potential (60 mV), were modestly VM-dependent,
increasing exponentially with a fractional electrical distance l = 0.175 0.00
as VM was made more negative. These findings suggest that Cr binding reac-tions are intrinsically VM-independent (Cr has no net charge), and that VM-
dependent steps may relate to Naþ and/or Cl, which are not rate-limiting at
150 mM NaCl. This point is currently being studied by determining the
[Naþ] dependence of the K0.5 for [Cr]o activation of current. Interestingly, an
additional inward current component appears at 20 mV, displaying a bell-
shaped current-VM relationship that peaks at þ10/þ20 mV, and increases with
[Cr]o. However, this current is independent ofCr transporter expression since oo-
cytes not injected with mRNA for SLC6A8 display similar currents (although
not bell-shaped) when are exposed to 500 mM Cro in the presence of 1 mM
intracellularly-injected Cr. This second component is also being characterized.
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Modulation of Proximal NaD Reabsorption is Related to the Fructose-
Induced Hypertension
Gabriella D. Queiroz-Leite, Elida A. Neri, Nancy A. Reboucas,
Gerhard Malnic.
University of Sao Paulo Institute of Biomedical Sciences, Sa˜o Paulo, Brazil.
Methods/Results: Wistar rats were fed for 2 or 8 weeks with control diet
(CTRL) or isocaloric 60% fructose diet (HF). Systolic blood pressure (SBP)
was measured weekly by tail cuff plethysmography. There was no difference
in the SBP after 2 weeks; however, there was an increase in SBP after 8 weeks
(P < 0.0001). 24h urine collected in metabolic cages showed a reduction in
urine flow (2 weeks - P = 0.0007 and 8 weeks - P = 0.001). Glomerular filtration
rate (GFR) was not altered after 2 weeks, but was decreased after 8 weeks (P =
0.001). Naþ fractional excretion (FE) was decreased after 2 weeks (P = 0.0131),
but was increased after 8 weeks (P = 0.038). After 2 or 8 weeks, rats were sub-
jected to in situ microperfusion experiments and had their proximal tubules
(TP) perfused with an alkaline solution to investigate Naþ reabsorption by
means of bicarbonate flux (JHCO3-, in nmol/cm2 x s). JHCO3- was increased
after 2 weeks (P < 0.0001) but was reduced after 8 weeks (P< 0.0001). Perfu-
sion using S3226, a specific NHE3 inhibitor, showed that fructose acts stimulat-
ingNHE3 activity after 2weeks (P< 0.0001) and inhibiting it after 8weeks (P<
0.0001). Conclusions: Reduced Naþ FE and urine flow, associated with in-
creased NHE3 activity after 2 weeks of HF suggest that initially fructose leads
to a state of Naþ overload, which may contribute to the development of hyper-
tension observed after 8 weeks of HF intake. Kidney damagewas increased after
8 weeks, since GFR was decreased, explaining the persistence of reduced urine
flow, despite reduced NHE3 activity. These data suggest that the mechanism of
pressure-natriuresis was activated after 8 weeks, in order to compensate for vol-
ume expansion.
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Fluoride Toxicity in Extreme Acid Stress: What’s a Bacterium to do?
Chunhui Ji, Randy Stockbridge, Christopher Miller.
Brandeis University and HHMI, Waltham, MA, USA.
Microorganisms face an environmental threat from F anions (present at
100mM in soil), which inhibit enolase and pyrophosphatase. Many microorgan-
isms possess fluoride exporters to reduce cellular F concentrations. Fluoride
toxicity is more troublesome at acidic pH levels, because membrane-
permeant HF (pKa ~3.4) from the acidic extracellular fluid diffuses into the
cytoplasm where it dissociates at the more neutral intracellular pH, thus trap-
ping and accumulating F at levlels much higher than the extracellular concen-
tration. Enteric bacteria, such as Escherichia coli, face a particularly extreme
acidic stress (pH < 2.5) encountered during their transit through the host stom-
ach. How, then, does E.coli survive the combination of elevated F concentra-
tion and extreme acidity? To address this, we exposed WT E.coli, E.coli with
its native F channel knocked out (DcrcB), and DcrcB cells expressing F ex-
porters from Piruella staleyi (pst) acid-shock media containing 1mM-10mM
NaF for 2 hours. Cells were then transferred to neutral LB media and their
survival rates and recovery times were monitored. For all strains, absolute sur-
vival rates decreased only as F concentration during acid-shock increased
above physiological levels (>100mM). But, different strains showed major
differences in the lengths of their recovery periods before growth after acid-
shock with F, even at low F concentrations. The DcrcB cells, despite having
the same absolute survival rate as WT cells, took 4 hours longer to begin divid-
ing than WT at 10mM F, whereas the lag time for DcrcB cells expressing the
F exporter Pst matched or was less than that ofWT at F concentration as high
as 1mM.
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Prolongation of Beating Rate Caused by Reduction of NCLX, a Mitochon-
drial NaD-Ca2D Exchanger, in Hl-1 Cardiomyocytes
Ayako Takeuchi1, Bongju Kim2, Satoshi Matsuoka2.
1Physiology and Biophysics, Kyoto University Graduate School of Medicine,
Kyoto, Japan, 2Center of Innovation in Immunoregulative Technology and
Therapeutics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
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Naþ-Ca2þ exchanger (NCXmit), a Ca
2þ extrusion system from mitochondria.
Although there have been accumulated data regarding roles of NCLX in
various kinds of cells, little is known about the roles in cardiomyocytes,
where repetitive Ca2þ transients occur and where a huge amount of ATP is
generated and utilized. In the present study, we carried out a combination
study of NCLX knockdown in spontaneously beating atrial cell line HL-1
and mathematical simulations. In HL-1 cells, NCLX knockdown by siRNA
reduced the protein expression by ~50%. A cytosolic Naþ-dependent mito-
chondrial Ca2þ efflux was decelerated by knocking down NCLX, confirming
that NCLX is a gene responsible for NCXmit in cardiomyocytes. Interestingly,
the cycle length of spontaneous Ca2þ oscillation and action potential generation
was significantly prolonged by knocking down NCLX. Detailed inspection
revealed that the rate of initial membrane depolarization and upstroke of
Ca2þ rise were markedly slower in the NCLX knockdown cells. Furthermore
Ca2þ content in sarcoplasmic reticulum (SR) was lower and SR Ca2þ reuptake
was slower in the NCLX knockdown cells. A mathematical model of HL-1 cells
showed that an automaticity of HL-1 cells are driven by a spontaneous Ca2þ
leak from SR, called ‘‘Ca2þ clock’’. Analyses using the model demonstrated
that blocking NCXmit reduced SR Ca
2þ content and SR Ca2þ leak, resulting
in the prolongation of beating rate. Taken together, the NCLX has an important
role in regulating cardiac automaticity by modulating ‘‘Ca2þ clock’’.
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Regulation of NaD/CA2D Exchanger by Pyridine Nucleotide Redox
Potential in Cardiac Myocytes
Ting Liu, Brian O’Rourke.
The Johns Hopkins University, Baltimore, MD, USA.
Cardiac Naþ/Ca2þ exchanger (NCX) is the major Ca2þ efflux pathway on the
sarcolemmal membrane, counterbalancing Ca2þ influx via L-type Ca2þ current
during excitation-contraction coupling. In humans, guinea pigs and large
mammals, NCX removes 20-25% of total cytosolic Ca2þ during relaxation.
Therefore, altered NCX activity can modulate SR Ca2þ load and contribute
to abnormal Ca2þ handling and arrhythmias. Here, we demonstrate that: 1)
increased NADH inhibits NCX current (INCX); 2) NCX inhibition by NADH
is reactive oxygen species (ROS)-dependent; 3) the NADH-induced ROS is
independent of the mitochondrial electron transportation chain (ETC). INCX
was measured with whole cell patch-clamp at 37C after dialyzing the cell
with various pipette solutions. With 400mM NADH in the pipette solution,
INCX (at þ80mV) was reduced by 65% compared to control. Endogenously
elevated cytosolic NADH by lactate perfusion (1mM) also inhibited INCX by
79% (at þ80mV) compared to control without lactate perfusion. Measurement
of ROS revealed that increasing cytosolic NADH increased ROS accumulation.
The NADH-induced increase in ROS, as well as the inhibition of INCX, was
abrogated by co-dialysis with the H2O2 scavenger catalase, demonstrating
that NCX inhibition is mediated by ROS. Inhibition of ETC with rotenone
did not reverse NCX inhibition by NADH, whereas D diphenylene iodonium
(DPI), which inhibits both the ETC and NAD(P)H oxidases, abolished NCX
inhibition. Lactate also induced ROS production in cell suspensions in
a dose-dependent manner, which was inhibited by DPI but not by rotenone,
NaCN, or antimycin A. Our findings indicate that NCX is regulated by cyto-
solic NADH/NADþ redox status through a ROS-dependent mechanism involv-
ing NAD(P)H oxidase, a mechanism that is likely to have profound effects on
Ca2þ homeostasis under conditions that alter cytosolic pyridine nucleotide
redox state, for example, during ischemia-reperfusion, diabetes or chronic heart
failure.
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Is ASP-454 Necessary for NaD and KD Binding in the Glutamate Trans-
porter EAAC1?
Juddy Mwaura1, Zhen Tao2, Herbert James1, Thomas Albers1,
Alexander Schwartz1, Christof Grewer1.
1Binghamton University, Binghamton, NY, USA, 21001 Rockville Pike
#105, Rockville, MD, USA.
The glutamate transporter Excitatory Amino Acid Carrier 1 (EAAC1) cata-
lyzes rapid removal of glutamate, the major excitatory neurotransmitter in
the brain, from the extracellular space, preventing its accumulation to neuro-
toxic levels. Uphill substrate transport is coupled to co-transport of 3 Naþ,
1 Hþ, and counter-transport of 1 Kþ ion. The cation binding sites are yet to
be fully identified in this transporter. Here, we investigate the role of the
highly conserved D454 residue which is thought to contribute its side chain
to coordinating these cations. D454 was mutated to the non-ionizable aspara-
gine, as well as alanine. Kþ-induced relocation was impaired in EAAC1-
D454N, as the transporter no longer catalyzed forward transport. Our findingsindicated that Kþ could still bind to EAAC1-D454N, but with reduced appar-
ent affinity. Naþ/glutamate exchange was functional in EAAC1-D454N, as
demonstrated by the presence of transient currents following rapid glutamate
application and voltage jumps. In the D454A mutant, glutamate application
inhibited inward leak anion currents, and transient currents in response to
voltage jumps were abolished. This is consistent with Naþ binding being
impaired in this transporter. Kþ binding was also eliminated by the D454A
mutation. Although D454 is proposed to participate in Naþ binding, its pro-
tonation state is yet to be established. pKa calculations for the bacterial homo-
logue Gltph indicate that D405 (analogous to D454) is protonated at
physiological pH with a highly perturbed pKa in the range of 7.6 to >14.
Valences calculated using the Poison-Boltzmann equation for EAAC1 with
D454 protonated (0.45) were close in value to the experimental values ob-
tained for EAAC1-D54N (0.71) and EAAC1-WT (0.64). Together, our results
suggest that D454 is protonated under physiological conditions, and partici-
pates in Naþ as well as Kþ binding.
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Transition Metal FRET to Study Extracelluar Gate Movement in
Glutamate Transporter
Xiaoyu Wang.
University of Miami Miller School of Medicine, Miami, FL, USA.
In the crystal structure of the bacterial glutamate transporter homologue
GltPH, an L-aspartate and two Naþ ions are bound within the core of each sub-
unit and bordered by two hairpin loops: HP1 from the intracellular side and
HP2 from the extracellular side. Notably, in another crystal structure of GltPH
bound with L-threo-b-benzyloxyaspartate (L-TBOA), a non-transportable sub-
strate analogue, TBOA locks the transporter in an outward-facing conforma-
tion similar to the aspartate-bound complex, except that HP2 adopts an
‘‘open’’ conformation, exposing the substrate binding site to the extracellular
solution. This suggests that HP2 may serve as an extracellular gate. In addition,
our published voltage clamp fluorometry measurements show that there are
significant Naþ-dependent movements of HP2 preceding glutamate binding.
Here we use transition-metal FRET to study the movements of HP2 in human
glutamate transporter EAAT3 upon binding of substrate and inhibitor. Com-
pared to the classical FRET methods which have previously been used by
our lab to measure conformational changes in EAAT3 during the glutamate
transport cycle, the transition metal ion FRET pairs are smaller in size and
have a shorter R0 value than the traditional FRET pairs, which enables us to
measure distance change within a very short range to better study the confor-
mation change of HP2 during ion and substrate binding. By labeling the FRET
donor fluorophore and the transition metal ion acceptor at different positions of
glutamate transporter EAAT3, we measured intrasubunit distance changes of
the HP2 region in the presence of glutamate compared with in the presence
of L-TBOA.
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Insights into the Human Glutamate Transporters from the Bacterial
Homolog Glt(Ph)
Germano Heinzelmann, Serdar Kuyucak.
University of Sydney, Sydney, Australia.
Human glutamate/aspartate transporters cotransport three Naþ and one Hþ ions
with the substrate and countertransport one Kþ ion. The archeal homolog
GltPh, which has a 36% sequence identity with the human transporters, trans-
ports aspartate and three sodium ions across the lipid membrane. We have pre-
viously performed Free Energy Perturbation (FEP) simulations of ligand
binding to GltPh in the extracellular(EC)-facing state, showing that the sub-
strate binds after two Naþ ions, with a strong water-mediated coupling between
the second sodium ion to bind (Na1) and the substrate. We have also performed
simulations and mutagenesis experiments to locate the binding site of the third
sodium ion (Na3), which could not be resolved in the crystal structure. More
recently, we have turned our focus to the intracellular(IC)-facing conformation
of GltPh. By running long unbiased simulations with different ligands bound to
the transporter, we were able to describe in details the gating mechanism and
point out the differences to the EC-facing state. The IC-facing FEP results dem-
onstrate that the unbinding of the ligands happens in a symmetrical manner,
with the ligands being released in the reverse order of their binding. The Na3
ion is, therefore, the first ligand to bind and the last to unbind. By means of
free energy calculations, Kramers’ theory and experiments, we are able to point
out the unbinding of the Na3 ion as the rate-limiting step in the transport mech-
anism. With all this information, we have built a homology model for a human
glutamate transporter (EAAT1) in different conformations, which can repro-
duce some of the differences observed in the transport mechanism of the human
and the bacterial transporters.
